C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer (Q39382631)

11 September 2017

title

C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer (English)

1 reference

11 September 2017

1 reference

6

1 reference

11 September 2017

13

Masaki Mori

1 reference

11 September 2017

12

Yuichiro Doki

1 reference

11 September 2017

2

Hirofumi Yamamoto

1 reference

11 September 2017

7

Ichiro Takemasa

1 reference

11 September 2017

8

Tsunekazu Mizushima

1 reference

11 September 2017

10

Mitsugu Sekimoto

1 reference

11 September 2017

11

Nariaki Matsuura

1 reference

11 September 2017

4

Masahisa Ohtsuka

1 reference

11 September 2017

3

Hidekazu Takahashi

1 reference

11 September 2017

Ryota Oshiro

1

1 reference

11 September 2017

Xin Wu

series ordinal

5

1 reference

11 September 2017

Masataka Ikeda

series ordinal

9

1 reference

11 September 2017

publication date

11 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

103

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1155-1164

1 reference

Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Cloning of the human homologue of the metastasis-associated rat C4.4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

C4.4A as a candidate marker in the diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Risk factors for an adverse outcome in early invasive colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Tumor budding as an index to identify high-risk patients with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2012.02263.X

Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer

21 January 2018

1 reference

12 December 2020

Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies

1 reference

12 December 2020

Upregulation of C4.4A expression during progression of melanoma

1 reference

12 December 2020

Prognostic value of tumor "budding" in patients with colorectal cancer

1 reference

12 December 2020

Developmentally regulated expression of metastasis-associated antigens in the rat.

1 reference

12 December 2020

Laminin-5 gamma2 chain expression as a possible determinant of tumor aggressiveness in T1 colorectal carcinomas

1 reference

12 December 2020

Tumour budding at invasive margins and outcome in colorectal cancer

1 reference

12 December 2020

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor

1 reference

12 December 2020

Predictors of extrahepatic recurrence after resection of colorectal liver metastases

1 reference

12 December 2020

The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

1 reference

12 December 2020

Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer

1 reference

12 December 2020

Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer

1 reference

12 December 2020

Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths

1 reference

12 December 2020

Correlation between tumor budding and post-resection prognosis in patients with invasive squamous cell carcinoma of the thoracic esophagus

1 reference

12 December 2020

Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.

1 reference

12 December 2020

Tumour budding detected by laminin-5 {gamma}2-chain immunohistochemistry is of prognostic value in epidermoid anal cancer

1 reference

12 December 2020

Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma

1 reference

12 December 2020

Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02263.X

Identifiers

DOI

1 reference

11 September 2017

1 reference